Presentation TCT 2025 TCT 643: Treatment of Aortic Stenosis in Patients with Active Cancer: Lifetime Management Considerations Presenter: Philipp Kiefer October 26, 2025 REGISTER for free or LOG IN to view this content TCT 2025 Up Next Presentation TCT 2025 TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis Presenter: Mahsa Rezasoltani October 26, 2025 More slides + Presentation TCT 2025 TCT 52: Differential Prognostic Impact of Potent P2Y12 inhibitors in Patients with Acute Myocardial Infarction According to Bleeding Risk Presenter: Seung Hun Lee October 26, 2025 Presentation TCT 2025 TCT 311: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A multi-center, randomized, parallel-controlled, non-inferiority clinical trial Presenter: Shasha Chen October 26, 2025 We Recommend Disclosures <p>Nothing to disclose</p>
Presentation TCT 2025 TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis Presenter: Mahsa Rezasoltani October 26, 2025
Presentation TCT 2025 TCT 52: Differential Prognostic Impact of Potent P2Y12 inhibitors in Patients with Acute Myocardial Infarction According to Bleeding Risk Presenter: Seung Hun Lee October 26, 2025
Presentation TCT 2025 TCT 311: Comparison of a novel occluder versus traditional occluder in atrial septal defect: A multi-center, randomized, parallel-controlled, non-inferiority clinical trial Presenter: Shasha Chen October 26, 2025